The dose range is 1.6-4.8 mg per injection: The standard KLOW dose is 3.2 mg total per injection: 2 mg GHK-Cu plus 0.4 mg each of BPC-157, TB-4, and KPV The low-end of the dose range is 1.6 mg, anchored on 1 mg of GHK-Cu with 200 mcg each of BPC-157, TB-4, and KPV The high-end of the dose range is 4.8 mg, anchored on 3 mg of GHK-Cu with 600 mcg each of BPC-157, TB-4, and KPV There is no trial-established dose for KLOW the dose range is mechanistically derived from a combination of each peptide
Since sermorelin stimulates natural HGH production, its effects are gradual compared to direct HGH injections but offer a safer and more sustainable approach
They are found in all living organisms and play a crucial role in biological activities
To be one of the people who reverses this condition, its important to take control of your health and develop habits you can sustain in the long-term
Indeed, the SURPASS-CVOT study, which compares tirzepatide head-to-head with dulaglutide, will likely provide more comprehensive answers (expected by the end of 2024)